Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of WDR3 mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of WDR3 mRNA | affects expression | 17562736
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of WDR3 mRNA | decreases expression | 20064835
|
D002995 |
Clofibric Acid |
Clofibric Acid affects the expression of WDR3 mRNA | affects expression | 17602206
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of WDR3 mRNA | decreases expression | 18042831
|
D008727 |
Methotrexate |
WDR3 protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
C041786 |
palm oil |
palm oil results in decreased expression of WDR3 mRNA | decreases expression | 18042831
|
D011374 |
Progesterone |
Progesterone results in decreased expression of WDR3 mRNA | decreases expression | 18037150
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of WDR3 mRNA | increases expression | 17879257
|
D013467 |
Sulindac |
Sulindac results in increased expression of WDR3 mRNA | increases expression | 11906190
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Sulindac |
5.76 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
4.48 | 12039119 |
MESH:D058186 |
Acute Kidney Injury |
|
Sulindac |
4.48 | 7897758 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.78 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Sulindac |
4.78 | 11910360 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
7.29 | 6695378 |
MESH:D000236 |
Adenoma |
|
Sulindac |
7.29 | 10223192 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Sulindac |
4.76 | 12394442 11874996 15623613 19003578 17611924 11535846 16460482 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.96 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.17 | 16712894 17306315 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.11 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.29 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
4.10 | 15238619 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.13 | 17286800 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
MESH:D001913 |
Bowen's Disease |
|
Sulindac |
5.62 | 11207687 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.60 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.47 | 15380490 15845082 15665606 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.41 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.41 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.41 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.41 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Sulindac |
2.41 | 16642371 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.67 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.67 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
4.67 | 16507464 17306315 15276417 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.74 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.74 | 18572023 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.67 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
3.10 | 19524636 20056578 |
MESH:D003110 |
Colonic Neoplasms |
|
Sulindac |
2.94 | 12902858 12458338 |
MESH:D015179 |
Colorectal Neoplasms |
|
Sulindac |
2.69 | 11076880 10666051 18059344 11197048 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
2.66 | 12039119 9562676 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.23 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.40 | 19747007 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.32 | 20191521 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.71 | 17187935 |
MESH:D003930 |
Diabetic Retinopathy |
|
Sulindac |
5.38 | 17621415 12861449 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
3.86 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
3.86 | 12594235 12958197 19370779 16081117 17562736 12705907 10774834 19085960 2444490 12153990 15619225 12540782 16393943 17522070 12392966 19923254 16485898 10663392 19164858 19739265 15968718 16227642 19420014 11421492 16781746 11287661 14725611 19416960 17906064 11743745 11461765 18071297 14550746 11834606 14986274 16177239 10915739 16109766 11739529 18713872 11529661 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.36 | 19426721 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.57 | 18367378 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.98 | 17692515 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
10.01 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Sulindac |
10.01 | 15652904 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.87 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Sulindac |
4.87 | 12235107 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
3.41 | 17967931 19551842 19004024 18296743 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Sulindac |
5.71 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Sulindac |
5.37 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
3.74 | 18296743 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.94 | 16983495 |
MESH:D005764 |
Gastroesophageal Reflux |
|
Sulindac |
5.21 | 11910360 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.92 | 16452187 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.36 | 16518429 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.74 | 20471113 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.30 | 12676792 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.84 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.76 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.80 | 21332399 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.62 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.10 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
8.99 | 20412841 |
MESH:D007249 |
Inflammation |
|
Progesterone |
8.99 | 15869954 |
MESH:D007249 |
Inflammation |
|
Sulindac |
8.99 | 3291741 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
3.21 | 18457598 11836018 |
MESH:D007414 |
Intestinal Neoplasms |
|
Sulindac |
4.80 | 12584176 12663524 12628509 10223192 12351151 10213222 |
MESH:D007417 |
Intestinal Polyps |
|
Sulindac |
5.17 | 11245490 12394442 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.27 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.27 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
3.12 | 16705839 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.29 | 9562676 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
7.25 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
7.25 | 14986274 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
Sulindac |
4.32 | 12468960 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
4.37 | 16611625 11587558 19460945 12587719 19784758 12969438 19014921 16610002 |
MESH:D008107 |
Liver Diseases |
|
Sulindac |
4.37 | 14986274 16867024 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.40 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.86 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
7.86 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.86 | 15276417 16712894 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.28 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
5.29 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.65 | 18520028 20135361 17053015 20064080 6695378 20869020 18569708 18816296 20464547 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.65 | 19931552 15276417 17077188 16712894 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Sulindac |
3.65 | 19359593 15713900 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
4.07 | 17352296 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
2.97 | 17203775 11408345 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.75 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Sulindac |
3.75 | 16642371 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.78 | 19513568 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.32 | 16381670 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.52 | 17488658 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.09 | 18551238 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.28 | 11141357 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.28 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.88 | 20056578 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.25 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
9.01 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Sulindac |
9.01 | 17266991 16850258 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.32 | 21332399 18674790 19632207 20518802 20132043 11836018 17217161 16723640 18457598 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.59 | 12819281 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
5.11 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
5.11 | 17306315 15276417 |
MESH:D010146 |
Pain |
|
Acetaminophen |
7.39 | 16870215 |
MESH:D010146 |
Pain |
|
Sulindac |
7.39 | 3291741 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Sulindac |
3.40 | 11504793 16820089 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.15 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.15 | 16039940 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.48 | 17410198 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.93 | 17352296 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.91 | 18045962 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.64 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.96 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.96 | 19524636 18572023 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.52 | 15862959 16503802 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.93 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.23 | 9562676 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.65 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.65 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.65 | 16452187 11723127 17306315 16712894 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.55 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.16 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.93 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Sulindac |
4.80 | 18645019 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.66 | 17056641 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.89 | 16723640 |